- Home
- JXG vs IMCC Comparison
JXG vs IMCC Comparison
Compare JXG & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JXG | IMCC |
|---|---|---|
| Founded | N/A | 1980 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 10.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JXG | IMCC |
|---|---|---|
| Price | $7.91 | $1.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 203.8K | ★ 276.1K |
| Earning Date | 05-14-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $46,835,624.00 | $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | $1.54 | ★ N/A |
| Revenue Growth | ★ 21.68 | 1.92 |
| 52 Week Low | $3.01 | $0.93 |
| 52 Week High | $73.80 | $7.12 |
Technical Indicators
Market Signals| Indicator | JXG | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 44.15 |
| Support Level | $8.44 | $1.33 |
| Resistance Level | $10.00 | $1.59 |
| Average True Range (ATR) | 1.62 | 0.23 |
| MACD | -0.15 | -0.03 |
| Stochastic Oscillator | 51.03 | 13.33 |
Price Performance
Historical ComparisonAbout JXG JX Luxventure Limited
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.